Osaic Holdings
PTGX icon

Osaic Holdings’s Protagonist Therapeutics PTGX Stock Holding History

Osaic Holdings’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126K Sell
1,197
-3,004
-72% -$266K ﹤0.01% 4508
2025
Q4 		$367K Buy
4,201
+2,810
+202% +$230K ﹤0.01% 3618
2025
Q3 		$91K Buy
1,391
+206
+17% +$11.7K ﹤0.01% 4865
2025
Q2 		$65.5K Buy
1,185
+525
+80% +$25.2K ﹤0.01% 4845
2025
Q1 		$31.9K Buy
660
+68
+11% +$2.85K ﹤0.01% 5030
2024
Q4 		$22.9K Buy
592
+414
+233% +$18K ﹤0.01% 5256
2024
Q3 		$8.01K Sell
178
-292
-62% -$11.8K ﹤0.01% 5952
2024
Q2 		$16.3K Sell
470
-2,081
-82% -$60.9K ﹤0.01% 5481
2024
Q1 		$73.8K Buy
2,551
+2,270
+808% +$61.8K ﹤0.01% 4466
2023
Q4 		$6.43K Sell
281
-31
-10% -$542 ﹤0.01% 6052
2023
Q3 		$5.2K Buy
+312
New +$6.05K ﹤0.01% 6256
2022
Q2 		– Sell
-57
Closed -$1K – 7537
2022
Q1 		$1K Hold
57
– – ﹤0.01% 7099
2021
Q4 		$2K Hold
57
– – ﹤0.01% 7043
2021
Q3 		$1K Sell
57
-173
-75% -$7.38K ﹤0.01% 7060
2021
Q2 		$11K Buy
230
+37
+19% +$1.22K ﹤0.01% 6011
2021
Q1 		$5K Sell
193
-966
-83% -$24.4K ﹤0.01% 6170
2020
Q4 		$24K Buy
1,159
+616
+113% +$13.3K ﹤0.01% 5050
2020
Q3 		$11K Sell
543
-9,540
-95% -$179K ﹤0.01% 5226
2020
Q2 		$178K Buy
10,083
+10,000
+12,048% +$125K ﹤0.01% 3236
2020
Q1 		$1K Buy
+83
New +$622 ﹤0.01% 5896

Other funds holding PTGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Osaic Holdings's PTGX Position: Q1 2026 in Review

Osaic Holdings reduced its Protagonist Therapeutics (PTGX) stake by 72% in Q1 2026, selling an estimated $266K and leaving 1,197 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #4508.

Osaic Holdings first reported a position in PTGX in Q1 2020 and has held it in 20 quarters since. The position peaked at $367K in Q4 2025. 317 funds tracked by Wall St. Rank hold PTGX as of Q1 2026.

  • Osaic Holdings held 1,197 shares of Protagonist Therapeutics worth $126K as of Q1 2026.
  • Osaic Holdings sold 3,004 Protagonist Therapeutics shares in Q1 2026, an estimated $266K.
  • Protagonist Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4508 holding.
  • Osaic Holdings first reported a position in Protagonist Therapeutics in Q1 2020 and has held it in 20 quarters since.
  • Osaic Holdings's Protagonist Therapeutics position peaked at $367K in Q4 2025.
  • 317 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.